A team of five Lübeck scientists has refined a method under which cells can be analyzed in connection with hereditary diseases, eliminating the need for biopsies of tissue from the affected organs. Instead, skin cells from patients are first reprogrammed to induced pluripotent stem cells (iPS) and then developed into nerve or muscle cells that reveal the donor’s complete genetic profile. The biotechnology start-up project IPS-HL has been awarded the BiomedTec 2014 prize by the Lübeck Sparkasse.
Aus/from: Life Science Nord Magazin 3/2014 (pages 16-17)
Download a pdf file
